Science without conscience is the soul’s perdition

Click here

The most Beautiful thing we can experience is the mysterious…

Click here

There is no Logical way to the discovery…

Click here


Why we are here

tech²ART is a Danish-based private company that throguh it's inovation technology strives to improve the outcome of assisted reproduction technology, the embryonic stem cell and cell culture technology at large. Through it's in- depth market knowledge, tech²ART has developed its first platform - the incuART, an advanced incubator platform that has been designed to provide superior environment and control of human cells and tissues incubation. The holistic idea is to design, assemble, market, sell and service a state-of-the art portfolio of equipment to address the demanding ART techniques at a premium. As we all know, the culture environment...

Our team

Who we are

tech²ART is a Danish based research, development and production company. The company’s team has in-depth knowledge within the industry – as well a privileged access to distribution channels and leading industry scientists around the world. We have emerged from working in the industry because we have observed a clear lack among current suppliers to fully capitalize on the market opportunities. tech²ART’s name represents the state-of-the-"ART" equipment and value proposition as well as the ART market segment. tech²ART’s business concept offers our customers a "Best in Class" experience when purchasing one of its products and/or services.


What type of products and services

tech²ART offers three types of products portfolio. The first one consists of equipment developed by our company and represents our main core competence. The second one consists of distributing 2nd party products and OEM's in order to respond to the customer needs of a more complete solution to complete our market needs. Addressing these needs, with focus on the whole cell culture process, we offer our customers a comprehensive training and local support program. The aim of the training program is to build a bridge in between new technologies and biotechnologies, a gap that often leads to critical failures and an unwanted outcome.